1999-33-3 Usage
Uses
Used in Pharmaceutical Industry:
H-GLY-ASN-OH is used as an active pharmaceutical ingredient for its potential therapeutic effects. The dipeptide structure allows it to interact with specific biological targets, making it a promising candidate for the development of new drugs.
Used in Cosmetics Industry:
H-GLY-ASN-OH is used as a key ingredient in the formulation of cosmetics for its moisturizing and skin-conditioning properties. Its ability to improve skin hydration and texture makes it a valuable addition to skincare products.
Used in Food and Beverage Industry:
H-GLY-ASN-OH is used as a flavor enhancer and a nutritional supplement in the food and beverage industry. Its dipeptide structure can contribute to the overall taste and nutritional value of various products, such as sports drinks, energy bars, and dietary supplements.
Used in Research and Development:
H-GLY-ASN-OH is used as a research tool in the field of biochemistry and molecular biology. Its unique properties make it an ideal candidate for studying peptide-protein interactions, enzyme activity, and other biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 1999-33-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,9,9 and 9 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1999-33:
(6*1)+(5*9)+(4*9)+(3*9)+(2*3)+(1*3)=123
123 % 10 = 3
So 1999-33-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H11N3O4/c7-2-5(11)9-3(6(12)13)1-4(8)10/h3H,1-2,7H2,(H2,8,10)(H,9,11)(H,12,13)
1999-33-3Relevant articles and documents
SYNTHESIS AND PROPERTIES OF PEPTIDE FRAGMENTS OF THE S-REGION OF THE SURFACE PROTEIN OF THE HEPTATITIS B VIRUS
Kuranova, I. L.,Churkina, S. I.,Os'mak, A. V.,Filonova, E. B.,Lyudmirova, V. L.,Noskova, O. V.
, p. 355 - 361 (2007/10/02)
A peptide fragment with the 140-146 sequence of the main component of the surface protein of the hepatitis B virus (HBsAG) and a number of its structural analogues have been synthesized by the classical method in solution.Conjugates of the peptides synthesized with bovine serum albumin and with a synthetic polypeptide analogue of polytuftsin have been obtained.The ability of the preparations to bind antibodies from the blood sera of hepatitis B patients has been studied.The possibility has been shown of their use for revealing antibodies to the heptatitis B virus in solid-phase enzyme-mediated immunoassay.
Novel substrate peptides
-
, (2008/06/13)
A peptide substrate for myristoylating enzymes is disclosed having an amino acid sequence selected from the group consisting of the following sequences or a physiologically acceptable amide or salt derivative thereof: STR1 wherein R=Ala, Asn, Gln or Ser; S=Ala, Arg, Gln, Glu, Phe or Ser; T=Ala or Lys; W=Ala or Ser; X=Ala, Tyr, or Lys; Y=Arg or Pro; and Z=Arg, Leu or Lys.